nach oben

Supportive Care in Cancer

Erschienen in:

01.08.2007 | Editorial

Evaluating supportive cancer care: are we missing an opportunity?

verfasst von: Marja Verhoef, Laura Weeks, Alison Brazier, Anne Leis

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Cancer care can be described as a system or complex network of interventions delivered at various times and places with different intentions.

Cancer care as a system

Cancer care can include medical treatments, psychosocial care, complementary and alternative medicine, self-care, as well as the process of healing and the context in which care is delivered.

Evaluating cancer care

Whereas evaluating individual cancer treatments can be difficult, evaluating cancer care is even more challenging and requires a research framework that relies on methodologies capable of addressing its holistic, individualized, and complex nature.

In summary

We suggest that research frameworks focused on studying complex or whole systems are a promising evaluation approach and an opportunity for further exploration.

Andersen B (1992) Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 60:552–568PubMedCrossRef

Bell IR, Caspi O, Schwartz GER, Grant K, Gaudet T, Rychener D, Maizes V, Weil A (2002) Integrative medicine and systemic outcomes research. Arch Intern Med 162:133–140PubMedCrossRef

Chan JJ, Chan JE (2000) Medicine for the millennium: the challenge of postmodernism. Med J Aust 172:332–334PubMed

Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J (2001) Influence of context effects on health outcomes: a systematic review. Lancet 357:757–762PubMedCrossRef

Fawzy I, Fawzy N, Arndt LA, Pasnau RO (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52:100–113PubMed

Goldfried MR, Eubanks-Carter C (2004) On the need for a new psychotherapy research paradigm: comment on Westen, Novotny, and Thomspon-Brenner (2004). Psychol Bull 130:669–673PubMedCrossRef

Institute of Medicine (2005) Need for innovative designs in research on CAM and conventional medicine. In: Complementary and alternative medicine in the United States. Committee on the use of Complementary and Alternative Medicine by the American Public. The National Academies Press, Washington, pp 108–128

Lipscomb J, Gotay C, Snyder C (2005) Introduction to outcomes assessment in cancer. In: Outcomes assessment in cancer: measures, methods, and applications. Cambridge University Press, Cambridge, UK, p 3

Meyer TJ, Mark MM (1995) Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 14:101–108PubMedCrossRef

10.

Ritenbaugh C (2006) Guiding concepts for whole systems research. In: Whole systems research in cancer care—report of meeting in Tromso (Sommaroy), 14–16 September 2005. Complement Ther Med 14:157–164

11.

Ritenbaugh C, Verhoef M, Fleishman S, Boon H, Leis A (2003) Whole systems research: a discipline for studying complementary and alternative medicine. Altern Ther Health Med 9:32–36PubMed

12.

Shapiro SL (2001) Quality of life and breast cancer: relationship to psychosocial variables. J Clin Psychol 57:501–519PubMedCrossRef

13.

Sidani S, Epstein DR, Moritz P (2003) An alternative paradigm for clinical nursing research: an exemplar. Res Nurs Health 26:244–255PubMedCrossRef

14.

Temoshok LR (2004) Rethinking research on psychosocial interventions in biopsychosocial oncology: an essay written in honor of the scholarly contributions of Bernard H. Fox. Psychooncology 13:460–467PubMedCrossRef

15.

Thomas K, Fitter M (2002) Possible research strategies for evaluating CAM interventions. In: Lewith G, Jonas WB, Walach H (eds) Clinical research in complementary therapies. Churchill Livingstone, London, pp 59–91

16.

Verhoef MJ, Lewith G, Ritenbaugh C, Boon H, Fleishman S, Leis A (2005) Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med 13:206–212PubMedCrossRef

17.

Verhoef MJ, Vanderheyden LC, Fonnebo V (2006) A whole systems research approach to cancer care: Why do we need it and how do we get started? Integr Cancer Ther 5:287–292PubMedCrossRef

Titel: Evaluating supportive cancer care: are we missing an opportunity?
verfasst von: Marja Verhoef
Laura Weeks
Alison Brazier
Anne Leis
Publikationsdatum: 01.08.2007
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 8/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-007-0289-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Evaluating supportive cancer care: are we missing an opportunity?

Abstract

Introduction

Cancer care as a system

Evaluating cancer care

In summary

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Introduction

Cancer care as a system

Evaluating cancer care

In summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2007

Twenty years of therapeutic touch in a Canadian cancer agency: lessons learned from a case study of integrative oncology practice

Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients

How to summarise and report written qualitative data from patients: a method for use in cancer support care

A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients

The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients

Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie